Pacific Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Revenue -23.30%
(FY 2017)
- Profit -24.69%
(FY 2017)
- Ebitda 85.25%
(FY 2017)
- Net Worth -89.23%
(FY 2017)
- Total Assets -11.84%
(FY 2017)
About Pacific Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Parminder Singh and Paramjit Singh serve as directors at the Company.
- CIN/LLPIN
U33110PB2007PTC031311
- Company No.
031311
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2007
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Amritsar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Pacific Diagnostics Private Limited offer?
Pacific Diagnostics Private Limited offers a wide range of products and services, including IVDs & Analyzers, Hematology Analyzers, Infusion Syringes & Supplies, Blood Collection Tubes, Laboratory Plasticware, Urine Containers, Medical Laboratory Instruments.
Who are the key members and board of directors at Pacific Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parminder Singh  | Managing Director | 13-Aug-2007 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Paramjit Singh | Director | 29-Oct-2012 | Current |
Financial Performance of Pacific Diagnostics.
Pacific Diagnostics Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 23.3% decrease. The company also saw a substantial fall in profitability, with a 24.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 89.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pacific Diagnostics?
In 2017, Pacific Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pacific Diagnostics?
Unlock and access historical data on people associated with Pacific Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pacific Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pacific Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
